G Panagos

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

Eric Van Cutsem, David Cunningham, W.W. ten Bokkel Huinink et al. · European Journal of Cancer · 1999 · 109 citations · Full text

Health Sciences, Medicine, Pharmacology +8

Combination Chemotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil in Previously Treated Patients With Advanced/Recurrent Head and Neck Cancer

Jim Janinis, M Papadakou, Emmanuel Xidakis et al. · American Journal of Clinical Oncology · 2000 · 73 citations

Sequential Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil in Patients With Locally Advanced Head and Neck Cancer

Jim Janinis, M Papadakou, G Panagos et al. · American Journal of Clinical Oncology · 2001 · 58 citations

Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation study

Ch. Kouroussis, E Xydakis, Anna Potamianou et al. · Annals of Oncology · 1999 · 37 citations · Full text

nCombination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: A multicenter phase II study of the Greek Cooperative Group for Lung Cancer

Vassilis Georgoulias, N. Androulakis, Demosthenes Bouros et al. · Lung Cancer · 1998 · 14 citations

Oncology, Greek Cooperative Group, Ncombination Chemotherapy +7